In the report just released they said that they had just enrolled their last patient in the phase 3 trial.
HT1
- Forums
- ASX - By Stock
- CSL
- News: CSL UPDATE 1-CSL's half-year profit beats estimates on robust blood plasma collections
News: CSL UPDATE 1-CSL's half-year profit beats estimates on robust blood plasma collections, page-37
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$300.42 |
Change
-0.350(0.12%) |
Mkt cap ! $146.5B |
Open | High | Low | Value | Volume |
$301.69 | $304.00 | $299.62 | $80.60M | 266.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 122 | $300.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$300.42 | 17 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 15 | 299.820 |
3 | 25 | 299.810 |
3 | 16 | 299.800 |
2 | 219 | 299.770 |
3 | 57 | 299.760 |
Price($) | Vol. | No. |
---|---|---|
299.880 | 90 | 7 |
299.890 | 49 | 5 |
299.910 | 56 | 4 |
299.940 | 11 | 1 |
299.970 | 25 | 1 |
Last trade - 11.58am 15/08/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online